ReproCELL Incorporated (TYO:4978)
127.00
+4.00 (3.25%)
Jun 3, 2026, 3:30 PM JST
ReproCELL Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,603 | 2,823 | 2,939 | 1,914 | 2,641 |
Short-Term Investments | 3,904 | 1,118 | 3,627 | 4,464 | 2,000 |
Cash & Short-Term Investments | 6,507 | 3,941 | 6,566 | 6,378 | 4,641 |
Cash Growth | 65.11% | -39.98% | 2.95% | 37.43% | 0.87% |
Receivables | 332 | 463 | 421 | 445 | 347 |
Inventory | 276 | 270 | 248 | 234 | 259 |
Other Current Assets | 214 | 222 | 164 | 125 | 132 |
Total Current Assets | 7,329 | 4,896 | 7,399 | 7,182 | 5,379 |
Property, Plant & Equipment | 282 | 241 | 199 | 101 | 97 |
Long-Term Investments | 1,967 | 4,450 | 1,429 | 1,057 | 2,589 |
Goodwill | 5 | 8 | 10 | 13 | 16 |
Other Intangible Assets | 8 | 18 | 14 | 1 | 13 |
Long-Term Deferred Tax Assets | 59 | 55 | - | - | - |
Other Long-Term Assets | 2 | 2 | 1 | 1 | 1 |
Total Assets | 9,652 | 9,670 | 9,052 | 8,355 | 8,095 |
Accounts Payable | 141 | 131 | 170 | 207 | 293 |
Accrued Expenses | 8 | 11 | 6 | 7 | 11 |
Current Portion of Long-Term Debt | - | - | - | - | 80 |
Current Income Taxes Payable | 149 | 125 | 85 | 165 | 68 |
Other Current Liabilities | 319 | 373 | 417 | 370 | 375 |
Total Current Liabilities | 617 | 640 | 678 | 749 | 827 |
Long-Term Deferred Tax Liabilities | 176 | 35 | 53 | 23 | 9 |
Other Long-Term Liabilities | 14 | 10 | 11 | 7 | 8 |
Total Liabilities | 807 | 685 | 742 | 779 | 844 |
Common Stock | 2,720 | 2,688 | 2,322 | 2,023 | 1,715 |
Additional Paid-In Capital | 6,276 | 6,244 | 6,380 | 6,081 | 6,313 |
Retained Earnings | -533 | 58 | -546 | -515 | -750 |
Comprehensive Income & Other | 382 | -5 | 154 | -13 | -27 |
Total Common Equity | 8,845 | 8,985 | 8,310 | 7,576 | 7,251 |
Shareholders' Equity | 8,845 | 8,985 | 8,310 | 7,576 | 7,251 |
Total Liabilities & Equity | 9,652 | 9,670 | 9,052 | 8,355 | 8,095 |
Total Debt | - | - | - | - | 80 |
Net Cash (Debt) | 6,507 | 3,941 | 6,566 | 6,378 | 4,561 |
Net Cash Growth | 65.11% | -39.98% | 2.95% | 39.84% | 0.89% |
Net Cash Per Share | 68.71 | 42.44 | 76.69 | 75.72 | 60.05 |
Filing Date Shares Outstanding | 94.74 | 94.69 | 89.59 | 85.11 | 83.23 |
Total Common Shares Outstanding | 94.74 | 94.69 | 88.94 | 85.11 | 82.24 |
Working Capital | 6,712 | 4,256 | 6,721 | 6,433 | 4,552 |
Book Value Per Share | 93.36 | 94.89 | 93.43 | 89.02 | 88.17 |
Tangible Book Value | 8,832 | 8,959 | 8,286 | 7,562 | 7,222 |
Tangible Book Value Per Share | 93.22 | 94.62 | 93.16 | 88.85 | 87.82 |